Meningococcal Sepsis in Patient with Paroxysmal Nocturnal Hemoglobinuria during Pegcetacoplan Therapy
Complement C5 inhibitors bring an increased risk for Neisseria infections. A novel complement C3 inhibitor, pegcetacoplan, was recently approved to treat paroxysmal nocturnal hemoglobinuria, a condition commonly treated with complement C5 inhibitors. We present a case of meningococcal sepsis in a p...
Salvato in:
| Autori principali: | , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Centers for Disease Control and Prevention
2025-03-01
|
| Serie: | Emerging Infectious Diseases |
| Soggetti: | |
| Accesso online: | https://wwwnc.cdc.gov/eid/article/31/3/24-1182_article |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|